Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)
Conditions: COVID-19 Infection; COVID-19 Vaccine Adverse Reaction Interventions: Biological: LEM-mR203; Biological: Placebo Sponsor: Lemonex Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Coronavirus | Covid Vaccine | COVID-19 | Research | Respiratory Medicine | SARS | Vaccines